Expression of MAGE-C1/CT7 provides prognostic information in multiple myeloma

Leuk Lymphoma. 2017 Jan;58(1):244-246. doi: 10.1080/10428194.2016.1187271. Epub 2016 Jun 1.

Authors

Peipei Xu¹, Liyu Zhang¹, Xiaohui Wang¹, Di Zhou¹, Jian Ouyang¹, Bing Chen¹

Affiliation

¹ a Department of Hematology , The Affiliated Drum Tower Hospital of Nanjing University Medical School , Nanjing , People's Republic of China.

PMID: 27248683
DOI: 10.1080/10428194.2016.1187271

No abstract available

Publication types

Letter

MeSH terms

Aged
Aged, 80 and over
Antigens, Neoplasm / biosynthesis
Antigens, Neoplasm / genetics*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Combined Modality Therapy
Female
Gene Expression Regulation, Neoplastic*
Hematopoietic Stem Cell Transplantation
Humans
Male
Middle Aged
Multiple Myeloma / genetics*
Multiple Myeloma / metabolism
Multiple Myeloma / therapy
Neoplasm Proteins / biosynthesis
Neoplasm Proteins / genetics*
Prognosis
Survival Analysis
Transplantation, Autologous
Treatment Outcome

Substances

Antigens, Neoplasm
MAGEC1 protein, human
Neoplasm Proteins